Dicerna Pharmaceuticals
DRNA
#3487
Rank
โ‚ฌ2.62 B
Marketcap
33,64ย โ‚ฌ
Share price
0.00%
Change (1 day)
16,261.69%
Change (1 year)

Revenue for Dicerna Pharmaceuticals (DRNA)

Revenue in 2021 (TTM): โ‚ฌ0.16 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue is โ‚ฌ0.16 Billion. In 2020 the company made a revenue of โ‚ฌ0.14 Billion an increase over the revenue in the year 2019 that were of โ‚ฌ21.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dicerna Pharmaceuticals from 2017 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ0.16 B12.64%
2020โ‚ฌ0.14 B587.36%
2019โ‚ฌ21.04 M287.05%
2018โ‚ฌ5.43 M171.23%
2017โ‚ฌ2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.2 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.00 B 32,892.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.97 B 1,065.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.48 B 33,173.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.41 B 17,231.60%๐Ÿ‡บ๐Ÿ‡ธ USA